Lupus Research Alliance News
Lupus Research Alliance Announces Nine Promising Novel Research Grant Awards

April 11, 2018 Nine Outstanding Investigators Receive Funding for Innovative Research on Lupus Causes, Pathways, and New Treatment Development Today, the Lupus Research Alliance announced nine new Novel Research Grants to support paradigm-changing lupus research. To conquer the complexity of lupus, the Novel Research Grants explore lupus from many perspectives, testing new theories about what […] READ MORE

Immunosuppressant Sirolimus May Offer a Lupus Treatment Option

April 5, 2018 A new clinical study published in the prestigious medical journal The Lancet found that sirolimus, a drug currently FDA approved to prevent organ transplant rejection, may offer a safe and effective treatment for lupus. In an accompanying editorial, Lupus Research Alliance Scientific Advisory Board Co-Chair Mary Crow, MD notes that in addition […] READ MORE

Phenom Lux – Stand Out and Help Out

March 29, 2018 Selena Gomez’s first design collaboration with PUMA, is the highly anticipated Phenom Lux—a shoe that is made to stand out and help out. Designed for training, but styled for slaying, Phenom Lux allows women not only to perform, but also take action. For this important first design collaboration between Selena and PUMA, […] READ MORE

Ablynx Announces Topline Results from the Phase II Study of Vobarilizumab in Patients with Systemic Lupus Erythematosus

March 26, 2018 Source: Ablynx Press Release 3.26.18 Ablynx today announced that the Phase II dose-ranging study of vobarilizumab, the Company’s anti-IL-6R Nanobody®, did not meet the primary endpoint of dose response based on the modified BILAG-based combined lupus assessment (mBICLA) at Week 24. The primary endpoint of the study was the percentage of subjects who […] READ MORE

2018 Omnibus Budget Passed March 23 Grants Lupus Advocates’ Requests

March 23, 2018 The Omnibus Appropriations bill for Fiscal Year 2018 that passed today includes key provisions the Lupus Research Alliance and lupus advocates have worked for all year. Lupus advocates, participating just days before for our annual March Capitol Hill Day, had requested program funding for 2019 and had asked legislators to also finish […] READ MORE

Our Funded Scientists Find Potential Target to Treat Kidney Disease

March 21, 2018   Lupus Research Alliance-Funded Scientists Find Potential Target to Treat Kidney Disease Novel research initially funded by the Lupus Research Alliance through a grant to Hospital for Special Surgery scientists significantly advanced understanding of kidney damage in lupus. As reported by Hospital for Special Surgery: A protein that helps regulate the body’s […] READ MORE

Advocate for Lupus – Contact Your Legislators

  Advocate for Lupus – Contact Your Legislators! March 21, 2018 The color purple and the word lupus filled the halls of the U.S. Capitol yesterday as over 90 determined advocates visited nearly 100 representatives, senators and staff to share why we need their support for lupus research. And we thank the PA FUND for […] READ MORE

Virtual Advocate for Lupus

        Join Us on the Hill March 20 as a Virtual Advocate for Lupus! Congress will be seeing purple next week when advocates representing the Lupus Research Alliance visit them Tuesday March 20 to convey why we need more funds for lupus research. We are proud to continue our March Hill Day […] READ MORE

Bacteria Could be to Blame for Autoimmune Attacks

March 12, 2018 Innovative novel research, co-funded by the Lupus Research Alliance, has produced a significant discovery about the role of bacteria and points to the potential for a vaccine or treatment that might prevent an autoimmune attack by suppressing specific bacteria. Led by Dr. Martin Kriegel at Yale University, the study was published today […] READ MORE

Lupus: Patient Voices Report Released Today

March 7, 2018 Lupus: Patient Voices Report Released Today We are pleased to announce the release of Lupus: Patient Voices, a comprehensive report based on input from the Externally-led Lupus Patient-Focused Drug Development (PFDD) Meeting and pre-meeting survey conducted last fall. This report includes data and personal accounts from people with lupus on symptoms, daily […] READ MORE

Lupus Industry Council Study Finds Inconsistency of ANA Tests

Lupus Industry Council Study Finds Inconsistency of ANA Tests A new study funded by the Lupus Research Alliance Lupus Industry Council shows that not all individuals who have been diagnosed with lupus remain positive for antinuclear antibodies (ANA) despite the long-held scientific belief to the contrary. Importantly, this study also reveals that whether a person […] READ MORE

Together, ManyOne Can make a difference!